Brookmont Capital Management
Brookmont Capital Management reported 64 stocks worth $176M in its 13F filing for Q3 2026, filed Oct 23, 2026. Its largest holdings are HD (26.2%), MSFT (3.7%) and GILD (3.2%). Compared with Q2 2026, the fund opened new positions in LIN, KR and XOM, added to MSFT, GILD and ADI, trimmed HD, JPM and SHEL and sold out of PEP, EMN and XOM.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  HD Home Depot Inc | $46.2M | 26.2% | 162K | −225 (−0%) | 8 of 8 | |
| 2 |  MSFT Microsoft Corp | $6.4M | 3.7% | 13K | +171 (+1%) | 8 of 8 | |
| 3 |  GILD Gilead Sciences Inc | $5.7M | 3.2% | 38K | +91 (+0%) | 8 of 8 | |
| 4 |  ADI Analog Devices Inc | $5.3M | 3.0% | 13K | +55 (+0%) | 8 of 8 | |
| 5 |  PG Procter & Gamble Co | $4.7M | 2.7% | 32K | +8,309 (+34%) | 8 of 8 | |
| 6 |  JPM Jpmorgan Chase & Co. | $4.7M | 2.7% | 14K | −3,305 (−19%) | 8 of 8 | |
| 7 |  SHEL Shell PLC | $4.6M | 2.6% | 48K | −12K (−20%) | 8 of 8 | |
| 8 |  AZN Astrazeneca PLC Ord | $4.4M | 2.5% | 27K | +836 (+3%) | 3 of 8 | |
| 9 |  ABT Abbott Labs | $4.4M | 2.5% | 44K | +6,918 (+18%) | 8 of 8 | |
| 10 |  LHX L3HARRIS Technologies in | $4.1M | 2.3% | 17K | +155 (+1%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Oct 23, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Brookmont Capital Management 13F FAQ
What does Brookmont Capital Management own?
Brookmont Capital Management reported 64 stocks worth $176M in its 13F filing for Q3 2026, filed Oct 23, 2026. Its largest holdings are HD (26.2%), MSFT (3.7%) and GILD (3.2%). The table above lists every position in the filing (the top 10 without an account).
What did Brookmont Capital Management buy and sell in Q3 2026?
Compared with Q2 2026: 6 new positions, 42 added to, 14 trimmed and 3 sold out. New positions include LIN, KR and XOM. It sold all of PEP, EMN and XOM.
When will Brookmont Capital Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Brookmont Capital Management's portfolio worth?
The Q3 2026 filing reports $176M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.